{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T13:18:50Z","timestamp":1788095930594,"version":"build-2803163510"},"reference-count":261,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2024,7,2]]},"abstract":"<jats:p>\u00a0Neuroimaging is increasingly being included in clinical trials of Huntington\u2019s disease (HD) for a wide range of purposes from participant selection and safety monitoring, through to demonstration of disease modification. Selection of the appropriate modality and associated analysis tools requires careful consideration. On behalf of the EHDN Imaging Working Group, we present current opinion on the utility and future prospects for inclusion of neuroimaging in HD trials. Covering the key imaging modalities of structural-, functional- and diffusion- MRI, perfusion imaging, positron emission tomography, magnetic resonance spectroscopy, and magnetoencephalography, we address how neuroimaging can be used in HD trials to: 1) Aid patient selection, enrichment, stratification, and safety monitoring; 2) Demonstrate biodistribution, target engagement, and pharmacodynamics; 3) Provide evidence for disease modification; and 4) Understand brain re-organization following therapy. We also present the challenges of translating research methodology into clinical trial settings, including equipment requirements and cost, standardization of acquisition and analysis, patient burden and invasiveness, and interpretation of results. We conclude, that with appropriate consideration of modality, study design and analysis, imaging has huge potential to facilitate effective clinical trials in HD.<\/jats:p>","DOI":"10.3233\/jhd-240016","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:10:10Z","timestamp":1716289810000},"page":"163-199","source":"Crossref","is-referenced-by-count":12,"title":["Neuroimaging to Facilitate Clinical Trials in Huntington\u2019s Disease: Current Opinion from the EHDN Imaging Working Group"],"prefix":"10.1177","volume":"13","author":[{"given":"Nicola Z.","family":"Hobbs","sequence":"first","affiliation":[{"name":"HD Research Centre, UCL Institute of Neurology, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Papoutsi","sequence":"additional","affiliation":[{"name":"HD Research Centre, UCL Institute of Neurology, UCL, London, UK"},{"name":"IXICO plc, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Delva","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, KU Leuven, Belgium"},{"name":"Department of Neurology, University Hospitals Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi M.","family":"Kinnunen","sequence":"additional","affiliation":[{"name":"IXICO plc, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"HD Research Centre, UCL Institute of Neurology, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven, Belgium"},{"name":"Division of Nuclear Medicine, University Hospitals Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, KU Leuven, Belgium"},{"name":"Department of Neurology, University Hospitals Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyantha","family":"Herath","sequence":"additional","affiliation":[{"name":"Alnylam Pharmaceuticals, Cambridge MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael I.","family":"Scahill","sequence":"additional","affiliation":[{"name":"HD Research Centre, UCL Institute of Neurology, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"6","key":"10.3233\/JHD-240016_ref1","first-page":"971","article-title":"The Huntington\u2019s Disease Collaborative Research Group","volume":"72","author":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","year":"1993","journal-title":"Cell"},{"key":"10.3233\/JHD-240016_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-71779-1_1","article-title":"Clinical features of Huntington\u2019s disease","volume":"1049","author":"Ghosh","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"10.3233\/JHD-240016_ref3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: Lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.3233\/JHD-240016_ref4","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1371\/journal.pcbi.0030235","article-title":"A universal mechanism ties genotype to phenotype in trinucleotide diseases","volume":"3","author":"Kaplan","year":"2007","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"10.3233\/JHD-240016_ref5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s13311-021-01027-4","article-title":"The use, standardization, and interpretation of brain imaging data in clinical trials of neurodegenerative disorders","volume":"18","author":"Schwarz","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.3233\/JHD-240016_ref6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.nic.2008.06.004","article-title":"Basic principles of magnetic resonance imaging","volume":"18","author":"McGowan","year":"2008","journal-title":"Neuroimaging Clin N Am"},{"issue":"3","key":"10.3233\/JHD-240016_ref7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jceh.2015.08.001","article-title":"Magnetic resonance imaging: Principles and techniques: Lessons for clinicians","volume":"5","author":"Grover","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.3233\/JHD-240016_ref8","doi-asserted-by":"crossref","first-page":"118751","DOI":"10.1016\/j.neuroimage.2021.118751","article-title":"Reliability of structural MRI measurements: The effects of scan session, head tilt, inter-scan interval, acquisition sequence, FreeSurfer version and processing stream","volume":"246","author":"Hedges","year":"2022","journal-title":"Neuroimage"},{"key":"10.3233\/JHD-240016_ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnins.2013.00031","article-title":"A hitchhiker\u2019s guide to diffusion tensor imaging","volume":"7","author":"Soares","year":"2013","journal-title":"Front Neurosci"},{"issue":"1","key":"10.3233\/JHD-240016_ref10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jnnp-2020-324377","article-title":"Diffusion imaging in Huntington\u2019s disease: Comprehensive review","volume":"92","author":"Estevez-Fraga","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"100","key":"10.3233\/JHD-240016_ref11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroimage.2013.12.003","article-title":"Why diffusion tensor MRI does well only some of the time: Variance and covariance of white matter tissue microstructure attributes in the living human brain","volume":"89","author":"De Santis","year":"2014","journal-title":"Neuroimage"},{"issue":"4","key":"10.3233\/JHD-240016_ref12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","article-title":"NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain","volume":"61","author":"Zhang","year":"2012","journal-title":"Neuroimage"},{"issue":"9","key":"10.3233\/JHD-240016_ref13","doi-asserted-by":"crossref","first-page":"e0217118","DOI":"10.1371\/journal.pone.0217118","article-title":"Optimizing the intrinsic parallel diffusivity in NODDI: An extensive empirical evaluation","volume":"14","author":"Guerrero","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.3233\/JHD-240016_ref14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroimage.2005.03.042","article-title":"Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain","volume":"27","author":"Assaf","year":"2005","journal-title":"Neuroimage"},{"issue":"11","key":"10.3233\/JHD-240016_ref15","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/hbm.25859","article-title":"Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRI","volume":"43","author":"Casella","year":"2022","journal-title":"Hum Brain Ma"},{"issue":"4","key":"10.3233\/JHD-240016_ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.25309","article-title":"In vivo characterization of white matter pathology in premanifest Huntington\u2019s disease","volume":"84","author":"Zhang","year":"2018","journal-title":"Ann Neurol"},{"issue":"4","key":"10.3233\/JHD-240016_ref17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.neuroimage.2006.02.024","article-title":"Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data","volume":"31","author":"Smith","year":"2006","journal-title":"Neuroimage"},{"issue":"24","key":"10.3233\/JHD-240016_ref18","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.87.24.9868","article-title":"Brain magnetic resonance imaging with contrast dependent on blood oxygenation","volume":"87","author":"Ogawa","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.3233\/JHD-240016_ref19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1388-2457(02)00038-X","article-title":"Technical aspects and utility of fMRI using BOLD and ASL","volume":"113","author":"Detre","year":"2002","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JHD-240016_ref20","doi-asserted-by":"crossref","unstructured":"Bailey D , Townsend D , Valk P , Maisey M . Positron Emission Tomography. 1ed. London:Springer; 2005. 382 p.","DOI":"10.1007\/b136169"},{"issue":"2","key":"10.3233\/JHD-240016_ref21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cpet.2015.09.002","article-title":"MR imaging-guided partial volume correction of PET data in PET\/MR imaging","volume":"11","author":"Erlandsson","year":"2016","journal-title":"PET Clin"},{"issue":"3","key":"10.3233\/JHD-240016_ref22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.rcl.2021.01.004","article-title":"Clinical applications of magnetic resonance spectroscopy in brain tumors: From diagnosis to treatment","volume":"59","author":"Weinberg","year":"2021","journal-title":"Radiol Clin North Am"},{"issue":"16","key":"10.3233\/JHD-240016_ref23","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/mds.23306","article-title":"In vivo neurochemistry of primary focal hand dystonia: A magnetic resonance spectroscopic neurometabolite profiling study at 3T","volume":"25","author":"Herath","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-240016_ref24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuron.2019.07.001","article-title":"Magnetoencephalography in cognitive neuroscience: A primer","volume":"104","author":"Gross","year":"2019","journal-title":"Neuron"},{"issue":"Pt 1","key":"10.3233\/JHD-240016_ref25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroimage.2013.11.005","article-title":"The relationship between MEG and fMRI","volume":"102","author":"Hall","year":"2014","journal-title":"Neuroimage"},{"issue":"4","key":"10.3233\/JHD-240016_ref26","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.neuroimage.2011.04.041","article-title":"MEG beamforming using Bayesian PCA for adaptive data covariance matrix regularization","volume":"57","author":"Woolrich","year":"2011","journal-title":"Neuroimage"},{"issue":"10","key":"10.3233\/JHD-240016_ref27","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jocn.2014.01.019","article-title":"Reduced automatic frontal response to auditory deviance in Huntington\u2019s disease as indexed by magnetic mismatch negativity","volume":"21","author":"Cheng","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"6","key":"10.3233\/JHD-240016_ref28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/mds.22485","article-title":"Whole-brain atrophy as a measure of progression in premanifest and early Huntington\u2019s disease","volume":"24","author":"Henley","year":"2009","journal-title":"Mov Disord"},{"issue":"4","key":"10.3233\/JHD-240016_ref29","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.neuroimage.2009.06.003","article-title":"Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington\u2019s disease","volume":"47","author":"Hobbs","year":"2009","journal-title":"Neuroimage"},{"issue":"5","key":"10.3233\/JHD-240016_ref30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1109\/42.640753","article-title":"The boundary shift integral: An accurate and robust measure of cerebral volume changes from registered repeat MRI","volume":"16","author":"Freeborough","year":"1997","journal-title":"IEEE Trans Med Imaging"},{"issue":"7","key":"10.3233\/JHD-240016_ref32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"A biological classification of Huntington\u2019s disease: The Integrated Staging System","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.3233\/JHD-240016_ref33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JHD-240016_ref34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: The 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.3233\/JHD-240016_ref35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: Analysis of 24 month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.3233\/JHD-240016_ref36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington\u2019s disease in the TRACK-HD study: Analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.3233\/JHD-240016_ref37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archneur.63.6.883","article-title":"Preparing for preventive clinical trials: The Predict-HD study","volume":"63","author":"Paulsen","year":"2006","journal-title":"Arch Neurol"},{"issue":"8","key":"10.3233\/JHD-240016_ref38","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: The Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-240016_ref39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2014.00078","article-title":"Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study","volume":"6","author":"Paulsen","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JHD-240016_ref40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2012.10.001","article-title":"Automated differentiation of pre-diagnosis Huntington\u2019s disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: The IMAGE-HD study","volume":"51","author":"Georgiou-Karistianis","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.3233\/JHD-240016_ref41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JHD-231512","article-title":"Freesurfer software update significantly impacts striatal volumes in the Huntington\u2019s disease young adult study and will influence HD-ISS staging","volume":"13","author":"Knights","year":"2024","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"10.3233\/JHD-240016_ref42","first-page":"2418","article-title":"Comparison of accuracy between FSL\u2019s FIRST and Freesurfer for caudate nucleus and putamen segmentation","volume":"7","author":"Perlaki","year":"2017","journal-title":"Sci Re"},{"key":"10.3233\/JHD-240016_ref43","doi-asserted-by":"crossref","first-page":"616272","DOI":"10.3389\/fneur.2021.616272","article-title":"Validating automated segmentation tools in the assessment of caudate atrophy in Huntington\u2019s disease","volume":"12","author":"Mansoor","year":"2021","journal-title":"Front Neurol"},{"issue":"11","key":"10.3233\/JHD-240016_ref44","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.27122","article-title":"Design optimization for clinical trials in early-stage manifest Huntington\u2019s disease","volume":"32","author":"Frost","year":"2017","journal-title":"Mov Disord"},{"issue":"11","key":"10.3233\/JHD-240016_ref45","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/mds.26803","article-title":"Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington\u2019s disease","volume":"31","author":"Harrington","year":"2016","journal-title":"Mov Disord"},{"issue":"3","key":"10.3233\/JHD-240016_ref46","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hbm.23465","article-title":"Longitudinal diffusion changes in prodromal and early HD: Evidence of white-matter tract deterioration","volume":"38","author":"Shaffer","year":"2017","journal-title":"Hum Brain Ma"},{"issue":"8","key":"10.3233\/JHD-240016_ref47","doi-asserted-by":"crossref","first-page":"e92641","DOI":"10.1172\/jci.insight.92641","article-title":"Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington\u2019s disease","volume":"2","author":"McColgan","year":"2017","journal-title":"JCI Insight"},{"key":"10.3233\/JHD-240016_ref48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinimag.2021.03.003","article-title":"Multi-parametric magnetic resonance imaging evaluation of cerebral amyloid angiopathy related inflammation: Case series and review of literature","volume":"78","author":"Nada","year":"2021","journal-title":"Clin Imaging"},{"issue":"2","key":"10.3233\/JHD-240016_ref49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.carj.2016.10.001","article-title":"Diffusion-weighted imaging of the brain: Beyond stroke","volume":"68","author":"Dmytriw","year":"2017","journal-title":"Can Assoc Radiol J"},{"issue":"1","key":"10.3233\/JHD-240016_ref50","first-page":"1252","article-title":"Resting-state connectivity stratifies premanifest Huntington\u2019s disease by longitudinal cognitive decline rate","volume":"10","author":"Polosecki","year":"2020","journal-title":"Sci Re"},{"issue":"3","key":"10.3233\/JHD-240016_ref51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.25171","article-title":"Predicting clinical diagnosis in Huntington\u2019s disease: An imaging polymarker","volume":"83","author":"Mason","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JHD-240016_ref52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mds.26838","article-title":"Validation of a prognostic index for Huntington\u2019s disease","volume":"32","author":"Long","year":"2017","journal-title":"Mov Disord"},{"issue":"12","key":"10.3233\/JHD-240016_ref53","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s00259-016-3483-5","article-title":"How reliable is (18)FDG PET for predicting the onset of Huntington\u2019s disease?","volume":"43","author":"Ciarmiello","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JHD-240016_ref54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2017.00011","article-title":"Molecular imaging markers to track Huntington\u2019s disease pathology","volume":"8","author":"Wilson","year":"2017","journal-title":"Front Neurol"},{"issue":"6","key":"10.3233\/JHD-240016_ref55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","article-title":"18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size","volume":"39","author":"Ciarmiello","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.3233\/JHD-240016_ref56","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00415-014-7350-7","article-title":"Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington\u2019s disease","volume":"261","author":"Herben-Dekker","year":"2014","journal-title":"J Neurol"},{"issue":"9","key":"10.3233\/JHD-240016_ref57","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1172\/JCI69411","article-title":"Metabolic network as a progression biomarker of premanifest Huntington\u2019s disease","volume":"123","author":"Tang","year":"2013","journal-title":"J Clin Invest"},{"issue":"30","key":"10.3233\/JHD-240016_ref58","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Tang","year":"2007","journal-title":"J Neurosci"},{"issue":"4","key":"10.3233\/JHD-240016_ref59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","article-title":"A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length","volume":"65","author":"Langbehn","year":"2004","journal-title":"Clin Genet"},{"issue":"12","key":"10.3233\/JHD-240016_ref60","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","article-title":"Striatal hypometabolism in premanifest and manifest Huntington\u2019s disease patients","volume":"43","author":"Lopez-Mora","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.3233\/JHD-240016_ref61","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","article-title":"Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: A multimodal imaging study","volume":"32","author":"Politis","year":"2011","journal-title":"Hum Brain Ma"},{"issue":"Pt 10","key":"10.3233\/JHD-240016_ref62","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/brain\/awv214","article-title":"Altered PDE10A expression detectable early before symptomatic onset in Huntington\u2019s disease","volume":"138","author":"Niccolini","year":"2015","journal-title":"Brain"},{"issue":"8","key":"10.3233\/JHD-240016_ref63","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1212\/WNL.0000000000002391","article-title":"Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging","volume":"86","author":"Russell","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.3233\/JHD-240016_ref64","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/mds.27963","article-title":"PET molecular imaging of phosphodiesterase 10A: An early biomarker of Huntington\u2019s disease progression","volume":"35","author":"Fazio","year":"2020","journal-title":"Mov Disord"},{"issue":"Pt 7","key":"10.3233\/JHD-240016_ref65","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington\u2019s disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.3233\/JHD-240016_ref66","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J Nucl Med"},{"issue":"9","key":"10.3233\/JHD-240016_ref67","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"J Nucl Med"},{"issue":"11","key":"10.3233\/JHD-240016_ref68","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp-2020-322904","article-title":"Data-driven evolution of neurosurgical gene therapy delivery in Parkinson\u2019s disease","volume":"91","author":"Richardson","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.3233\/JHD-240016_ref69","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.neuroimage.2012.03.075","article-title":"Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain","volume":"62","author":"Jenkins","year":"2012","journal-title":"Neuroimage"},{"issue":"4","key":"10.3233\/JHD-240016_ref70","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hbm.23516","article-title":"Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry","volume":"38","author":"Khalili-Mahani","year":"2017","journal-title":"Hum Brain Ma"},{"issue":"7","key":"10.3233\/JHD-240016_ref71","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1038\/tp.2013.43","article-title":"Use of functional imaging across clinical phases in CNS drug development","volume":"3","author":"Borsook","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JHD-240016_ref73","doi-asserted-by":"crossref","first-page":"109752","DOI":"10.1016\/j.ejrad.2021.109752","article-title":"Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging","volume":"140","author":"Reneman","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.3233\/JHD-240016_ref74","doi-asserted-by":"crossref","first-page":"107807","DOI":"10.1016\/j.neuropharm.2019.107807","article-title":"Spatiotemporal brain activation pattern following acute citalopram challenge is dose dependent and associated with neuroticism: A human phMRI study","volume":"170","author":"Edes","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.3233\/JHD-240016_ref75","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0269881118822263","article-title":"Temporal dynamics of the pharmacological MRI response to subanaesthetic ketamine in healthy volunteers: A simultaneous EEG\/fMRI study","volume":"33","author":"McMillan","year":"2019","journal-title":"J\u00a0Psychopharmacol"},{"issue":"10","key":"10.3233\/JHD-240016_ref76","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: New insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"Pt 8","key":"10.3233\/JHD-240016_ref77","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/brain\/awf180","article-title":"Impaired glutamate transport and glutamate-glutamine cycling: Downstream effects of the Huntington mutation","volume":"125","author":"Behrens","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JHD-240016_ref78","first-page":"17977","article-title":"Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates","volume":"11","author":"Herrmann","year":"2021","journal-title":"Sci Re"},{"issue":"1","key":"10.3233\/JHD-240016_ref79","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acs.jmedchem.2c01585","article-title":"Design and evaluation of [(18)F]CHDI-650 as a positron emission tomography ligand to image mutant huntingtin aggregates","volume":"66","author":"Liu","year":"2023","journal-title":"J Med Chem"},{"issue":"630","key":"10.3233\/JHD-240016_ref80","doi-asserted-by":"crossref","first-page":"eabm3682","DOI":"10.1126\/scitranslmed.abm3682","article-title":"Development of a ligand for in vivo imaging of mutant huntingtin in Huntington\u2019s disease","volume":"14","author":"Bertoglio","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.3233\/JHD-240016_ref81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-031-32815-2_6","volume-title":"Biomarkers for Huntington\u2019s Disease","author":"Everix","year":"2023"},{"issue":"1","key":"10.3233\/JHD-240016_ref82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00259-022-05945-z","article-title":"Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [(11)C]CHDI\u2013R and [(11)C]CHDI-designed for quantification of cerebral aggregated mutant huntingtin","volume":"50","author":"Delva","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.3233\/JHD-240016_ref83","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntington\u2019s disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"issue":"10","key":"10.3233\/JHD-240016_ref84","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/mds.28686","article-title":"The emerging role of phosphodiesterases in movement disorders","volume":"36","author":"Erro","year":"2021","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240016_ref85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-319-58811-7_11","article-title":"Role of phosphodiesterases in Huntington\u2019s Disease","volume":"17","author":"Fusco","year":"2017","journal-title":"Adv Neurobiol"},{"issue":"2","key":"10.3233\/JHD-240016_ref86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jnnp-2017-316633","article-title":"Striatal molecular alterations in HD gene carriers: A systematic review and meta-analysis of PET studies","volume":"89","author":"Niccolini","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-240016_ref87","first-page":"A99","article-title":"J06 A randomized, double-blind, placebo-controlled phase ii efficacy and safety study of the PDE10A inhibitor PF-in Huntington disease (amaryllis)","volume":"89","author":"Delnomdedieu","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.3233\/JHD-240016_ref88","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mds.28855","article-title":"A MDS evidence-based review on treatments for Huntington\u2019s disease","volume":"37","author":"Ferreira","year":"2022","journal-title":"Mov Disord"},{"issue":"13","key":"10.3233\/JHD-240016_ref89","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/mds.23236","article-title":"A futility study of minocycline in Huntington\u2019s disease","volume":"25","author":"Huntington Study Group DI","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"10.3233\/JHD-240016_ref90","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.apsb.2020.08.006","article-title":"Recent developments on PET radiotracers for TSPO and their applications in neuroimaging","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.3233\/JHD-240016_ref91","doi-asserted-by":"crossref","first-page":"fcad084","DOI":"10.1093\/braincomms\/fcad084","article-title":"A PET-CT study on neuroinflammation in Huntington\u2019s disease patients participating in a randomized trial with laquinimod","volume":"5","author":"Roussakis","year":"2023","journal-title":"Brain Commun"},{"issue":"1","key":"10.3233\/JHD-240016_ref92","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1212\/WNL.0000000000012969","article-title":"Synaptic damage and its clinical correlates in people with early Huntington disease: A PET study","volume":"98","author":"Delva","year":"2022","journal-title":"Neurology"},{"issue":"11","key":"10.3233\/JHD-240016_ref93","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","article-title":"Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease","volume":"29","author":"Wilton","year":"2023","journal-title":"Nat Med"},{"issue":"7","key":"10.3233\/JHD-240016_ref94","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","article-title":"Prospects for cannabinoid therapies in basal ganglia disorders","volume":"163","author":"Fernandez-Ruiz","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"1607","key":"10.3233\/JHD-240016_ref95","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"10.3233\/JHD-240016_ref96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1176\/jnp.2006.18.4.553","article-title":"Nabilone could treat chorea and irritability in Huntington\u2019s disease","volume":"18","author":"Curtis","year":"2006","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.3233\/JHD-240016_ref97","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/molecules25030482","article-title":"Huntington\u2019s disease: A review of the known PET imaging biomarkers and targeting radiotracers","volume":"25","author":"Cybulska","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.3233\/JHD-240016_ref98","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1755-5949.2010.00134.x","article-title":"Dopamine and glutamate in Huntington\u2019s disease: A balancing act","volume":"16","author":"Andre","year":"2010","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"10.3233\/JHD-240016_ref99","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/0269881114536790","article-title":"The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG)","volume":"28","author":"Muthukumaraswamy","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"15","key":"10.3233\/JHD-240016_ref100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.cub.2011.06.053","article-title":"An in vivo assay of synaptic function mediating human cognition","volume":"21","author":"Moran","year":"2011","journal-title":"Curr Biol"},{"key":"10.3233\/JHD-240016_ref101","doi-asserted-by":"crossref","first-page":"117189","DOI":"10.1016\/j.neuroimage.2020.117189","article-title":"Generative modelling of the thalamo-cortical circuit mechanisms underlying the neurophysiological effects of ketamine","volume":"221","author":"Shaw","year":"2020","journal-title":"Neuroimage"},{"issue":"7","key":"10.3233\/JHD-240016_ref102","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/brain\/awab097","article-title":"GABAergic cortical network physiology in frontotemporal lobar degeneration","volume":"144","author":"Adams","year":"2021","journal-title":"Brain"},{"issue":"12","key":"10.3233\/JHD-240016_ref104","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/jnnp-2014-309768","article-title":"Short-interval observational data to inform clinical trial design in Huntington\u2019s disease","volume":"86","author":"Hobbs","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.3233\/JHD-240016_ref105","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A2018","article-title":"Onset and progression of pathologic atrophy in Huntington disease: A longitudinal MR imaging study","volume":"31","author":"Hobbs","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.3233\/JHD-240016_ref106","doi-asserted-by":"crossref","first-page":"e74131","DOI":"10.1371\/journal.pone.0074131","article-title":"Multi-modal neuroimaging in premanifest and early Huntington\u2019s disease: 18 month longitudinal data from the IMAGE-HD study","volume":"8","author":"Dominguez","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JHD-240016_ref107","doi-asserted-by":"crossref","first-page":"712555","DOI":"10.3389\/fneur.2021.712555","article-title":"Volumetric MRI-based biomarkers in Huntington\u2019s disease: An evidentiary review","volume":"12","author":"Kinnunen","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.3233\/JHD-240016_ref108","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","article-title":"Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington\u2019s disease Young Adult Study (HD-YAS): A cross-sectional analysis","volume":"19","author":"Scahill","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-240016_ref109","unstructured":"(FDA) USFaDA. Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review 2023."},{"issue":"6","key":"10.3233\/JHD-240016_ref110","doi-asserted-by":"crossref","first-page":"e890","DOI":"10.1212\/WNL.0000000000011121","article-title":"Association of dilated perivascular spaces and disease severity in patients with Huntington disease","volume":"96","author":"Chan","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.3233\/JHD-240016_ref111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JHD-231508","article-title":"Assessment of perivascular space morphometry across the white matter in Huntington\u2019s disease using MRI","volume":"13","author":"Coleman","year":"2024","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"10.3233\/JHD-240016_ref112","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/hbm.21205","article-title":"Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington\u2019s disease","volume":"33","author":"Dumas","year":"2012","journal-title":"Hum Brain Ma"},{"issue":"5","key":"10.3233\/JHD-240016_ref113","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/hbm.22733","article-title":"Basal ganglia-cortical structural connectivity in Huntington\u2019s disease","volume":"36","author":"Novak","year":"2015","journal-title":"Hum Brain Ma"},{"key":"10.3233\/JHD-240016_ref114","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nbd.2014.01.013","article-title":"White matter connectivity reflects clinical and cognitive status in Huntington\u2019s disease","volume":"65","author":"Poudel","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-240016_ref115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nicl.2012.12.001","article-title":"Evaluation of multi-modal, multi-site neuroimaging measures in Huntington\u2019s disease: Baseline results from the PADDINGTON study","volume":"2","author":"Hobbs","year":"2012","journal-title":"Neuroimage Clin"},{"issue":"9","key":"10.3233\/JHD-240016_ref116","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","article-title":"Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: Selective white matter pathology and its relationship to clinical measures","volume":"21","author":"Rosas","year":"2006","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240016_ref117","doi-asserted-by":"crossref","unstructured":"Odish OF , Leemans A , Reijntjes RH , van den Bogaard SJ , Dumas EM , Wolterbeek R , et al. Microstructural brain abnormalities in Huntington\u2019s disease: A two-year follow-uHum Brain Ma. 2015;36(6):2061\u201374.","DOI":"10.1002\/hbm.22756"},{"issue":"3","key":"10.3233\/JHD-240016_ref118","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00062-019-00805-0","article-title":"Microstructural white matter alterations in mild cognitive impairment and Alzheimer\u2019s disease: Study based on neurite orientation dispersion and density imaging (NODDI)","volume":"30","author":"Fu","year":"2020","journal-title":"Clin Neuroradiol"},{"issue":"3","key":"10.3233\/JHD-240016_ref119","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jnnp.2007.142786","article-title":"A longitudinal diffusion tensor imaging study in symptomatic Huntington\u2019s disease","volume":"81","author":"Sritharan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JHD-240016_ref120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","article-title":"Longitudinal change in white matter microstructure in Huntington\u2019s disease: The IMAGE-HD study","volume":"74","author":"Poudel","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.3233\/JHD-240016_ref121","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/JHD-150173","article-title":"Longitudinal diffusion tensor imaging shows progressive changes in white matter in Huntington\u2019s disease","volume":"4","author":"Gregory","year":"2015","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240016_ref122","doi-asserted-by":"crossref","first-page":"116835","DOI":"10.1016\/j.neuroimage.2020.116835","article-title":"SANDI: A compartment-based model for non-invasive apparent soma and neurite imaging by diffusion MRI","volume":"215","author":"Palombo","year":"2020","journal-title":"Neuroimage"},{"key":"10.3233\/JHD-240016_ref123","doi-asserted-by":"crossref","first-page":"102927","DOI":"10.1016\/j.nicl.2021.102927","article-title":"Timing of selective basal ganglia white matter loss in premanifest Huntington\u2019s disease","volume":"33","author":"Zeun","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"3","key":"10.3233\/JHD-240016_ref124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11682-011-9121-8","article-title":"Diffusion tensor imaging in Huntington\u2019s disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits","volume":"5","author":"Bohanna","year":"2011","journal-title":"Brain Imaging Behav"},{"key":"10.3233\/JHD-240016_ref125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cortex.2017.04.001","article-title":"Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington\u2019s disease: 30 months IMAGE-HD data","volume":"92","author":"Dominguez","year":"2017","journal-title":"Cortex"},{"issue":"5","key":"10.3233\/JHD-240016_ref126","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/mds.28489","article-title":"Composite UHDRS correlates with progression of imaging biomarkers in Huntington\u2019s disease","volume":"36","author":"Estevez-Fraga","year":"2021","journal-title":"Mov Disord"},{"key":"10.3233\/JHD-240016_ref127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nicl.2012.12.005","article-title":"Evaluating multicenter DTI data in Huntington\u2019s disease on site specific effects: An ex post facto approach","volume":"2","author":"Muller","year":"2013","journal-title":"Neuroimage Clin"},{"issue":"5","key":"10.3233\/JHD-240016_ref128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mds.25864","article-title":"The cognitive burden in Huntington\u2019s disease: Pathology, phenotype, and mechanisms of compensation","volume":"29","author":"Papoutsi","year":"2014","journal-title":"Mov Disord"},{"issue":"4","key":"10.3233\/JHD-240016_ref129","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/brain\/awx022","article-title":"Operationalizing compensation over time in neurodegenerative disease","volume":"140","author":"Gregory","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JHD-240016_ref130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neubiorev.2018.03.003","article-title":"A critical review of brain and cognitive reserve in Huntington\u2019s disease","volume":"88","author":"Soloveva","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.3233\/JHD-240016_ref131","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/hbm.24790","article-title":"Aberrant brain network connectivity in presymptomatic and manifest Huntington\u2019s disease: A systematic review","volume":"41","author":"Pini","year":"2020","journal-title":"Hum Brain Ma"},{"key":"10.3233\/JHD-240016_ref132","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fpsyt.2014.00132","article-title":"Attempted and successful compensation in preclinical and early manifest neurodegeneration \u2013 a review of task FMRI studies","volume":"5","author":"Scheller","year":"2014","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.3233\/JHD-240016_ref133","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bandc.2013.07.004","article-title":"Functional and connectivity changes during working memory in Huntington\u2019s disease: 18 month longitudinal data from the IMAGE-HD study","volume":"83","author":"Georgiou-Karistianis","year":"2013","journal-title":"Brain Cogn"},{"issue":"1","key":"10.3233\/JHD-240016_ref134","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00429-013-0670-z","article-title":"Functional changes during working memory in Huntington\u2019s disease: 30-month longitudinal data from the IMAGE-HD study","volume":"220","author":"Poudel","year":"2015","journal-title":"Brain Struct Funct"},{"issue":"1","key":"10.3233\/JHD-240016_ref135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/hbm.22616","article-title":"Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington\u2019s disease gene carriers: A three-year follow-up study","volume":"36","author":"Odish","year":"2015","journal-title":"Hum Brain Ma"},{"issue":"11","key":"10.3233\/JHD-240016_ref136","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1002\/hbm.23299","article-title":"Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington\u2019s disease","volume":"37","author":"Gargouri","year":"2016","journal-title":"Hum Brain Ma"},{"issue":"3","key":"10.3233\/JHD-240016_ref137","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.neuroimage.2011.08.105","article-title":"Stability of resting fMRI interregional correlations analyzed in subject-native space: A one-year longitudinal study in healthy adults and premanifest Huntington\u2019s disease","volume":"59","author":"Seibert","year":"2012","journal-title":"Neuroimage"},{"key":"10.3233\/JHD-240016_ref138","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.expneurol.2012.10.020","article-title":"Prefrontal activity in Huntington\u2019s disease reflects cognitive and neuropsychiatric disturbances: The IMAGE-HD study","volume":"239","author":"Gray","year":"2013","journal-title":"Exp Neurol"},{"issue":"5","key":"10.3233\/JHD-240016_ref139","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/hbm.22296","article-title":"Functional magnetic resonance imaging of working memory in Huntington\u2019s disease: Cross-sectional data from the IMAGE-HD study","volume":"35","author":"Georgiou-Karistianis","year":"2014","journal-title":"Hum Brain Ma"},{"issue":"3","key":"10.3233\/JHD-240016_ref140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"10.3233\/JHD-240016_ref141","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","article-title":"Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: Potential implications for its pathophysiology","volume":"78","author":"Drouin-Ouellet","year":"2015","journal-title":"Ann Neurol"},{"issue":"9","key":"10.3233\/JHD-240016_ref142","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/jcbfm.2011.60","article-title":"Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington\u2019s disease","volume":"31","author":"Wolf","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.3233\/JHD-240016_ref143","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuroimage.2011.08.112","article-title":"Complex relationships between cerebral blood flow and brain atrophy in early Huntington\u2019s disease","volume":"59","author":"Chen","year":"2012","journal-title":"Neuroimage"},{"issue":"3","key":"10.3233\/JHD-240016_ref144","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.26118","article-title":"A longitudinal study of magnetic resonance spectroscopy Huntington\u2019s disease biomarkers","volume":"30","author":"Sturrock","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.3233\/JHD-240016_ref145","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1212\/WNL.53.4.806","article-title":"Clinical correlation of striatal 1H MRS changes in Huntington\u2019s disease","volume":"53","author":"Sanchez-Pernaute","year":"1999","journal-title":"Neurology"},{"issue":"6","key":"10.3233\/JHD-240016_ref146","doi-asserted-by":"crossref","first-page":"fcac258","DOI":"10.1093\/braincomms\/fcac258","article-title":"Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington\u2019s disease","volume":"4","author":"Lowe","year":"2022","journal-title":"Brain Commun"},{"key":"10.3233\/JHD-240016_ref147","doi-asserted-by":"crossref","first-page":"147704","DOI":"10.1016\/j.brainres.2021.147704","article-title":"Metabolomics in degenerative brain diseases","volume":"1773","author":"Quintero","year":"2021","journal-title":"Brain Res"},{"issue":"3","key":"10.3233\/JHD-240016_ref148","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","article-title":"PET scan investigations of Huntington\u2019s disease: Cerebral metabolic correlates of neurological features and functional decline","volume":"20","author":"Young","year":"1986","journal-title":"Ann Neurol"},{"issue":"6","key":"10.3233\/JHD-240016_ref149","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.410230603","article-title":"Positron emission tomographic scan investigations of Huntington\u2019s disease: Cerebral metabolic correlates of cognitive function","volume":"23","author":"Berent","year":"1988","journal-title":"Ann Neurol"},{"issue":"Pt 5","key":"10.3233\/JHD-240016_ref150","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington\u2019s disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"issue":"6","key":"10.3233\/JHD-240016_ref151","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jnr.25174","article-title":"Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington\u2019s disease","volume":"101","author":"Horta-Barba","year":"2023","journal-title":"J Neurosci Res"},{"issue":"7","key":"10.3233\/JHD-240016_ref152","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.27395","article-title":"Structural and metabolic brain correlates of apathy in Huntington\u2019s disease","volume":"33","author":"Martinez-Horta","year":"2018","journal-title":"Mov Disord"},{"issue":"Pt 7","key":"10.3233\/JHD-240016_ref153","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/brain\/121.7.1343","article-title":"The relationship between striatal dopamine receptor binding and cognitive performance in Huntington\u2019s disease","volume":"121","author":"Lawrence","year":"1998","journal-title":"Brain"},{"issue":"Pt 11","key":"10.3233\/JHD-240016_ref154","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington\u2019s disease: An in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"issue":"Pt 5","key":"10.3233\/JHD-240016_ref155","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: A PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"issue":"Pt 12","key":"10.3233\/JHD-240016_ref156","first-page":"2353","article-title":"Huntington\u2019s disease progression","volume":"122","author":"Andrews","year":"1999","journal-title":"PET and clinical observations. Brain"},{"issue":"Pt 12","key":"10.3233\/JHD-240016_ref157","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington\u2019s disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"Backman","year":"1997","journal-title":"Brain"},{"issue":"Pt 3","key":"10.3233\/JHD-240016_ref158","first-page":"689","article-title":"Striatal D1 and D2 receptor binding in patients with Huntington\u2019s disease and other choreas","volume":"118","author":"Turjanski","year":"1995","journal-title":"A PET study. Brain"},{"issue":"12","key":"10.3233\/JHD-240016_ref159","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaneurol.2014.1954","article-title":"The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease","volume":"71","author":"Russell","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.3233\/JHD-240016_ref160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jns.2016.07.033","article-title":"Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington\u2019s disease gene carriers","volume":"368","author":"Wilson","year":"2016","journal-title":"J Neurol Sci"},{"issue":"11","key":"10.3233\/JHD-240016_ref161","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: A clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.3233\/JHD-240016_ref162","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1177\/0271678X17724947","article-title":"Kinetic evaluation and test-retest reproducibility of [(11)C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans","volume":"38","author":"Finnema","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.3233\/JHD-240016_ref163","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2967\/jnumed.120.249144","article-title":"First-in-human evaluation of (18)F-SynVesT-1, a radioligand for PET imaging of synaptic vesicle glycoprotein 2A","volume":"62","author":"Naganawa","year":"2021","journal-title":"J Nucl Med"},{"issue":"1","key":"10.3233\/JHD-240016_ref164","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2967\/jnumed.109.067074","article-title":"Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands","volume":"51","author":"Terry","year":"2010","journal-title":"J Nucl Med"},{"issue":"1","key":"10.3233\/JHD-240016_ref165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2967\/jnumed.118.210393","article-title":"Behavioral symptoms in premanifest Huntington disease correlate with reduced frontal CB1R levels","volume":"60","author":"Ceccarini","year":"2019","journal-title":"J Nucl Med"},{"issue":"Pt 6","key":"10.3233\/JHD-240016_ref166","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JHD-240016_ref167","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3988\/jcn.2013.9.1.21","article-title":"Decreased metabolism in the cerebral cortex in early-stage Huntington\u2019s disease: A possible biomarker of disease progression?","volume":"9","author":"Shin","year":"2013","journal-title":"J Clin Neurol"},{"issue":"2","key":"10.3233\/JHD-240016_ref168","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410430216","article-title":"[11C]raclopride-PET studies of the Huntington\u2019s disease rate of progression: Relevance of the trinucleotide repeat length","volume":"43","author":"Antonini","year":"1998","journal-title":"Ann Neurol"},{"issue":"2","key":"10.3233\/JHD-240016_ref169","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2009.10.015","article-title":"Cortical dopamine dysfunction in symptomatic and premanifest Huntington\u2019s disease gene carriers","volume":"37","author":"Pavese","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-240016_ref170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2018.08.006","article-title":"PET Radioligands for imaging of the PDE10A in human: Current status","volume":"691","author":"Boscutti","year":"2019","journal-title":"Neurosci Lett"},{"issue":"8","key":"10.3233\/JHD-240016_ref171","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/mds.29501","article-title":"Longitudinal imaging of regional brain volumes, SV2A, and glucose metabolism in Huntington\u2019s disease","volume":"38","author":"Delva","year":"2023","journal-title":"Mov Disord"},{"issue":"6","key":"10.3233\/JHD-240016_ref172","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington\u2019s disease","volume":"43","author":"Pagano","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.3233\/JHD-240016_ref173","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JHD-200002","article-title":"Huntington\u2019s Disease Clinical Trials Corner: April 2020","volume":"9","author":"Rodrigues","year":"2020","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-240016_ref174","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","article-title":"Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease","volume":"76","author":"Southwell","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"10","key":"10.3233\/JHD-240016_ref175","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41591-022-01919-8","article-title":"Pepinemab antibody blockade of SEMA4D in early Huntington\u2019s disease: A randomized, placebo-controlled, phase 2 trial","volume":"28","author":"Feigin","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"10.3233\/JHD-240016_ref176","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-009-1103-3","article-title":"Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins","volume":"36","author":"Squitieri","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.3233\/JHD-240016_ref177","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ana.21181","article-title":"Riluzole in Huntington\u2019s disease: A 3-year, randomized controlled study","volume":"62","author":"Landwehrmeyer","year":"2007","journal-title":"Ann Neurol"},{"issue":"5","key":"10.3233\/JHD-240016_ref178","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: A randomized clinical trial","volume":"53","author":"Kremer","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JHD-240016_ref179","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/WNF.0b013e31821c31d8","article-title":"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease","volume":"34","author":"Esmaeilzadeh","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JHD-240016_ref180","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.ynirp.2021.100034","article-title":"Basal ganglia activation localized in MEG using a reward task","volume":"1","author":"Sepe-Forrest","year":"2021","journal-title":"Neuroimage Rep"},{"issue":"2","key":"10.3233\/JHD-240016_ref181","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00406-018-0968-1","article-title":"Caudothalamic dysfunction in drug-free suicidally depressed patients: An MEG study","volume":"270","author":"Chattun","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"7","key":"10.3233\/JHD-240016_ref182","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.clinph.2017.04.024","article-title":"Changes in resting-state directed connectivity in cortico-subcortical networks correlate with cognitive function in Parkinson\u2019s disease","volume":"128","author":"Boon","year":"2017","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.3233\/JHD-240016_ref183","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2012.02.029","article-title":"Cognitive decline in Parkinson\u2019s disease is associated with slowing of resting-state brain activity: A longitudinal study","volume":"34","author":"Olde Dubbelink","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.3233\/JHD-240016_ref184","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neuron.2017.11.026","article-title":"White matter plasticity in the adult brain","volume":"96","author":"Sampaio-Baptista","year":"2017","journal-title":"Neuron"},{"issue":"8","key":"10.3233\/JHD-240016_ref185","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/mds.28109","article-title":"A critical review of white matter changes in Huntington\u2019s disease","volume":"35","author":"Casella","year":"2020","journal-title":"Mov Disord"},{"issue":"4","key":"10.3233\/JHD-240016_ref186","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jnr.24358","article-title":"Altered brain iron content and deposition rate in Huntington\u2019s disease as indicated by quantitative susceptibility MRI","volume":"97","author":"Chen","year":"2019","journal-title":"J Neurosci Res"},{"issue":"5","key":"10.3233\/JHD-240016_ref187","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3174\/ajnr.A4617","article-title":"Quantitative susceptibility mapping suggests altered brain iron in premanifest Huntington disease","volume":"37","author":"van Bergen","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3233\/JHD-240016_ref188","doi-asserted-by":"crossref","first-page":"103266","DOI":"10.1016\/j.ebiom.2021.103266","article-title":"Altered iron and myelin in premanifest Huntington\u2019s disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study","volume":"65","author":"Johnson","year":"2021","journal-title":"EBioMedicine"},{"key":"10.3233\/JHD-240016_ref189","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2017.05.042","article-title":"Myelin breakdown in human Huntington\u2019s disease: Multi-modal evidence from diffusion MRI and quantitative magnetization transfer","volume":"403","author":"Bourbon-Teles","year":"2019","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-240016_ref190","doi-asserted-by":"crossref","first-page":"102658","DOI":"10.1016\/j.nicl.2021.102658","article-title":"Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington\u2019s disease","volume":"30","author":"Casella","year":"2021","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JHD-240016_ref191","first-page":"2010","article-title":"Structural brain plasticity: Individual differences and changes with learning","author":"Scholz","journal-title":"PQDT \u2013 UK & Ireland"},{"issue":"35","key":"10.3233\/JHD-240016_ref192","doi-asserted-by":"crossref","first-page":"11670","DOI":"10.1523\/JNEUROSCI.2567-10.2010","article-title":"Dynamic properties of human brain structure: Learning-related changes in cortical areas and associated fiber connections","volume":"30","author":"Taubert","year":"2010","journal-title":"J Neurosci"},{"issue":"6","key":"10.3233\/JHD-240016_ref193","doi-asserted-by":"crossref","first-page":"e3001290","DOI":"10.1371\/journal.pbio.3001290","article-title":"Rapid microstructural plasticity in the cortical semantic network following a short language learning session","volume":"19","author":"Vukovic","year":"2021","journal-title":"PLoS Biol"},{"key":"10.3233\/JHD-240016_ref194","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnana.2012.00032","article-title":"Experience-dependent plasticity in white matter microstructure: Reasoning training alters structural connectivity","volume":"6","author":"Mackey","year":"2012","journal-title":"Front Neuroanat"},{"issue":"2","key":"10.3233\/JHD-240016_ref195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1017\/cjn.2021.64","article-title":"Corpus callosum remodeling in glioma: Constancy of fiber density and anisotropy in MRI","volume":"49","author":"Pareek","year":"2022","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JHD-240016_ref196","doi-asserted-by":"crossref","first-page":"104880","DOI":"10.1016\/j.bandl.2020.104880","article-title":"Signatures of brain plasticity supporting language recovery after perinatal arterial ischemic stroke","volume":"212","author":"Francois","year":"2021","journal-title":"Brain Lang"},{"issue":"1","key":"10.3233\/JHD-240016_ref197","doi-asserted-by":"crossref","first-page":"e86496","DOI":"10.1371\/journal.pone.0086496","article-title":"Neural plasticity in human brain connectivity: The effects of long term deep brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease","volume":"9","author":"van Hartevelt","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JHD-240016_ref198","doi-asserted-by":"crossref","first-page":"102931","DOI":"10.1016\/j.nicl.2021.102931","article-title":"MRI markers of functional connectivity and tissue microstructure in stroke-related motor rehabilitation: A systematic review","volume":"33","author":"Tavazzi","year":"2022","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.3233\/JHD-240016_ref199","doi-asserted-by":"crossref","first-page":"fcaa049","DOI":"10.1093\/braincomms\/fcaa049","article-title":"Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington\u2019s disease","volume":"2","author":"Papoutsi","year":"2020","journal-title":"Brain Commun"},{"issue":"2","key":"10.3233\/JHD-240016_ref200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brs.2008.11.002","article-title":"Consensus paper: Combining transcranial stimulation with neuroimaging","volume":"2","author":"Siebner","year":"2009","journal-title":"Brain Stimul"},{"issue":"1","key":"10.3233\/JHD-240016_ref201","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-018-0347-1","article-title":"Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer\u2019s disease and mild cognitive impairment: A critical review","volume":"10","author":"Canu","year":"2018","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.3233\/JHD-240016_ref202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/agm2.12017","article-title":"Functional MRI technologies in the study of medication treatment effect on Alzheimer\u2019s disease","volume":"1","author":"Guo","year":"2018","journal-title":"Aging Med (Milton)"},{"issue":"7","key":"10.3233\/JHD-240016_ref203","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/brain\/awy122","article-title":"Testing a longitudinal compensation model in premanifest Huntington\u2019s disease","volume":"141","author":"Gregory","year":"2018","journal-title":"Brain"},{"issue":"14","key":"10.3233\/JHD-240016_ref204","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1002\/hbm.24695","article-title":"Network spread determines severity of degeneration and disconnection in Huntington\u2019s disease","volume":"40","author":"Poudel","year":"2019","journal-title":"Hum Brain Ma"},{"issue":"1","key":"10.3233\/JHD-240016_ref205","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41380-021-01350-4","article-title":"Prion-like properties of the mutant huntingtin protein in living organisms: The evidence and the relevance","volume":"27","author":"Alpaugh","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JHD-240016_ref206","doi-asserted-by":"crossref","first-page":"118008","DOI":"10.1016\/j.neuroimage.2021.118008","article-title":"Network model of pathology spread recapitulates neurodegeneration and selective vulnerability in Huntington\u2019s disease","volume":"235","author":"Raj","year":"2021","journal-title":"Neuroimage"},{"issue":"8","key":"10.3233\/JHD-240016_ref207","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nn.3761","article-title":"Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons","volume":"17","author":"Pecho-Vrieseling","year":"2014","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.3233\/JHD-240016_ref208","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2012.02.095","article-title":"Impaired cortico-striatal functional connectivity in prodromal Huntington\u2019s Disease","volume":"514","author":"Unschuld","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-240016_ref209","doi-asserted-by":"crossref","first-page":"689332","DOI":"10.3389\/fncel.2021.689332","article-title":"Huntingtin and the synapse","volume":"15","author":"Barron","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"Pt 8","key":"10.3233\/JHD-240016_ref210","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/brain\/awv145","article-title":"Network topology and functional connectivity disturbances precede the onset of Huntington\u2019s disease","volume":"138","author":"Harrington","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.3233\/JHD-240016_ref211","doi-asserted-by":"crossref","first-page":"e00424","DOI":"10.1002\/brb3.424","article-title":"Correlation between resting state fMRI total neuronal activity and PET metabolism in healthy controls and patients with disorders of consciousness","volume":"6","author":"Soddu","year":"2016","journal-title":"Brain Behav"},{"key":"10.3233\/JHD-240016_ref212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroimage.2018.04.048","article-title":"Simultaneous resting-state FDG-PET\/fMRI in Alzheimer disease: Relationship between glucose metabolism and intrinsic activity","volume":"176","author":"Marchitelli","year":"2018","journal-title":"Neuroimage"},{"key":"10.3233\/JHD-240016_ref213","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroimage.2019.04.034","article-title":"Functional resting-state brain connectivity is accompanied by dynamic correlations of application-dependent [(18)F]FDG PET-tracer fluctuations","volume":"196","author":"Amend","year":"2019","journal-title":"Neuroimage"},{"key":"10.3233\/JHD-240016_ref214","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fneur.2016.00035","article-title":"Magnetoencephalography in stroke recovery and rehabilitation","volume":"7","author":"Paggiaro","year":"2016","journal-title":"Front Neurol"},{"key":"10.3233\/JHD-240016_ref215","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nicl.2015.09.011","article-title":"Functional connectivity changes detected with magnetoencephalography after mild traumatic brain injury","volume":"9","author":"Dimitriadis","year":"2015","journal-title":"Neuroimage Clin"},{"issue":"8","key":"10.3233\/JHD-240016_ref216","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1162\/jocn_a_01561","article-title":"Language neuroplasticity in brain tumor patients revealed by magnetoencephalography","volume":"32","author":"Piai","year":"2020","journal-title":"J Cogn Neurosci"},{"issue":"1","key":"10.3233\/JHD-240016_ref217","doi-asserted-by":"crossref","first-page":"63","DOI":"10.17576\/jskm-2018-1601-08","article-title":"Assessing neuroplasticity using magnetoencephalography (MEG) in patient with left-temporo-parietal pilocytic astrocytomas treated with endoscopic surgery","volume":"16","author":"Manan","year":"2018","journal-title":"J Sains Kesihatan Malaysia"},{"issue":"Pt B","key":"10.3233\/JHD-240016_ref218","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuropsychologia.2016.04.006","article-title":"Hemispheric contributions to language reorganisation: An MEG study of neuroplasticity in chronic post stroke aphasia","volume":"93","author":"Mohr","year":"2016","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.3233\/JHD-240016_ref219","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1474-4422(23)00454-4","article-title":"Safety and efficacy of laquinimod for Huntington\u2019s disease (LEGATO-HD): A multicentre, randomised, double-blind, placebo-controlled, phase 2 study","volume":"23","author":"Reilmann","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.3233\/JHD-240016_ref220","doi-asserted-by":"crossref","unstructured":"Barkhof F , Knopman DS . Brain shrinkage in anti-beta-amyloid Alzheimer trials: Neurodegeneration or pseudoatrophy? Neurology. 2023;100(20):941\u20132.","DOI":"10.1212\/WNL.0000000000207268"},{"issue":"3","key":"10.3233\/JHD-240016_ref221","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/01.WNL.0000150542.16969.CC","article-title":"Dehydration confounds the assessment of brain atrophy","volume":"64","author":"Duning","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JHD-240016_ref222","unstructured":"Reilmann R , Gordon M , Feigin A , Anderson K , Tabrizi S , Leavitt B , et al. Brain MRI volume changes after 12 months laquinimod treatment of Huntington disease (LEGATO-HD) [abstract]. Mov Disord 2019;34(suppl 2). https:\/\/www.mdsabstracts.org\/abstract\/brain-mri-volume-changes-after-12-months-laquinimod-treatment-of-huntington-disease-legato-hd\/."},{"key":"10.3233\/JHD-240016_ref223","first-page":"53","article-title":"J01 Triheptanoin is associated with clinical stability and decreased caudate atrophy in Huntington disease","volume":"92","author":"Mochel","year":"2021","journal-title":"J Neurol Neurosurg PsychiatryA"},{"issue":"1","key":"10.3233\/JHD-240016_ref224","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mds.28359","article-title":"Hydrocephalus complicating intrathecal antisense oligonucleotide therapy for Huntington\u2019s disease","volume":"36","author":"Stoker","year":"2021","journal-title":"Mov Disord"},{"issue":"24","key":"10.3233\/JHD-240016_ref225","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"issue":"3-4","key":"10.3233\/JHD-240016_ref226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13554794.2019.1617319","article-title":"Disproportionately enlarged subarachnoid-space hydrocephalus (DESH) in normal pressure hydrocephalus misinterpreted as atrophy: Autopsy and radiological evidence","volume":"25","author":"McCarty","year":"2019","journal-title":"Neurocase"},{"key":"10.3233\/JHD-240016_ref227","unstructured":"Dr Ronald Crystal: FDA Center for Biologies Evaluation and Research, 70th Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee. Sept 2021."},{"key":"10.3233\/JHD-240016_ref228","unstructured":"Leavitt B. Brain huntingtin and tominersen levels following intrathecal administration of tominersen in manifest Huntington\u2019s disease. 18th Annual HD Therapeutics Conference; 2023; Dubrovnik, Croatia."},{"key":"10.3233\/JHD-240016_ref229","unstructured":"Cole JH , Farmer RE , Rees EM , Johnson HJ , Frost C , Scahill RI , et al. Test-retest reliability of diffusion tensor imaging in Huntington\u2019s disease. PLoS Curr. 2014;6:Ecurrents.hd.f19ef63fff962f5cd9c0e88f4844f43b."},{"issue":"5","key":"10.3233\/JHD-240016_ref230","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/jmri.27203","article-title":"Longitudinal structural MRI in neurologically healthy adults","volume":"52","author":"Gregory","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.3233\/JHD-240016_ref231","doi-asserted-by":"crossref","first-page":"117406","DOI":"10.1016\/j.neuroimage.2020.117406","article-title":"MICRA: Microstructural image compilation with repeated acquisitions","volume":"225","author":"Koller","year":"2021","journal-title":"Neuroimage"},{"key":"10.3233\/JHD-240016_ref232","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mri.2018.03.004","article-title":"Empirical reproducibility, sensitivity, and optimization of acquisition protocol, for Neurite Orientation Dispersion and Density Imaging using AMICO","volume":"50","author":"Parvathaneni","year":"2018","journal-title":"Magn Reson Imaging."},{"issue":"8","key":"10.3233\/JHD-240016_ref233","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1089\/brain.2021.0123","article-title":"Structural Brain network reproducibility: Influence of different diffusion acquisition and tractography reconstruction schemes on graph metrics","volume":"12","author":"Borrelli","year":"2022","journal-title":"Brain Connect"},{"key":"10.3233\/JHD-240016_ref234","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fnins.2015.00167","article-title":"phMRI: Methodological considerations for mitigating potential confounding factors","volume":"9","author":"Bourke","year":"2015","journal-title":"Front Neurosci"},{"issue":"10","key":"10.3233\/JHD-240016_ref235","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ebiom.2015.08.002","article-title":"Compensation in preclinical Huntington\u2019s disease: Evidence from the Track-On HD Study","volume":"2","author":"Kloppel","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"10.3233\/JHD-240016_ref236","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hbm.20502","article-title":"Cortical dysfunction in patients with Huntington\u2019s disease during working memory performance","volume":"30","author":"Wolf","year":"2009","journal-title":"Hum Brain Ma"},{"key":"10.3233\/JHD-240016_ref237","doi-asserted-by":"crossref","first-page":"116157","DOI":"10.1016\/j.neuroimage.2019.116157","article-title":"A decade of test-retest reliability of functional connectivity: A systematic review and meta-analysis","volume":"203","author":"Noble","year":"2019","journal-title":"Neuroimage"},{"issue":"4","key":"10.3233\/JHD-240016_ref238","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/hbm.23517","article-title":"Test-retest reliability of functional connectivity networks during naturalistic fMRI paradigms","volume":"38","author":"Wang","year":"2017","journal-title":"Hum Brain Ma"},{"key":"10.3233\/JHD-240016_ref239","doi-asserted-by":"crossref","first-page":"116860","DOI":"10.1016\/j.neuroimage.2020.116860","article-title":"Towards clinical applications of movie fMRI","volume":"217","author":"Eickhoff","year":"2020","journal-title":"Neuroimage"},{"issue":"4","key":"10.3233\/JHD-240016_ref240","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jmri.22345","article-title":"Test-retest reliability of arterial spin labeling with common labeling strategies","volume":"33","author":"Chen","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.3233\/JHD-240016_ref241","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.25197","article-title":"Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia","volume":"73","author":"Alsop","year":"2015","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.3233\/JHD-240016_ref242","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3","volume":"49","author":"Guedj","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JHD-240016_ref243","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbi.2020.10.025","article-title":"Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: Implications for inflammation and depression","volume":"91","author":"Turkheimer","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.3233\/JHD-240016_ref244","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000002329","article-title":"Selection of reference regions to model neurodegeneration in Huntington disease by 18F-FDG PET\/CT using imaging and clinical parameters","volume":"44","author":"Lopez Mora","year":"2019","journal-title":"Clin Nucl Med"},{"issue":"Suppl 1","key":"10.3233\/JHD-240016_ref245","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.2967\/jnumed.121.263201","article-title":"Imaging of synaptic density in neurodegenerative disorders","volume":"63","author":"Carson","year":"2022","journal-title":"J Nucl Med"},{"issue":"2","key":"10.3233\/JHD-240016_ref246","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00259-018-4119-8","article-title":"Quantifying SV2A density and drug occupancy in the human brain using [(11)C]UCB-J PET imaging and subcortical white matter as reference tissue","volume":"46","author":"Koole","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.3233\/JHD-240016_ref247","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in Huntington\u2019s disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process","volume":"23","author":"Rub","year":"2013","journal-title":"Brain Pathol"},{"issue":"6","key":"10.3233\/JHD-240016_ref248","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington\u2019s disease (HD): The neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","author":"Rub","year":"2016","journal-title":"Brain Pathol"},{"issue":"6","key":"10.3233\/JHD-240016_ref249","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-011-1745-9","article-title":"The importance of appropriate partial volume correction for PET quantification in Alzheimer\u2019s disease","volume":"38","author":"Thomas","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.3233\/JHD-240016_ref250","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.13130531","article-title":"Clinical proton MR spectroscopy in central nervous system disorders","volume":"270","author":"Oz","year":"2014","journal-title":"Radiology"},{"issue":"6","key":"10.3233\/JHD-240016_ref251","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/mrm.29164","article-title":"Plug-and-play advanced magnetic resonance spectroscopy","volume":"87","author":"Deelchand","year":"2022","journal-title":"Magn Reson Med"},{"issue":"2","key":"10.3233\/JHD-240016_ref252","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mrm.27742","article-title":"Methodological consensus on clinical proton MRS of the brain: Review and recommendations","volume":"82","author":"Wilson","year":"2019","journal-title":"Magn Reson Med"},{"issue":"5","key":"10.3233\/JHD-240016_ref253","doi-asserted-by":"crossref","first-page":"e4218","DOI":"10.1002\/nbm.4218","article-title":"Across-vendor standardization of semi-LASER for single-voxel MRS at 3T","volume":"34","author":"Deelchand","year":"2021","journal-title":"NMR Biomed"},{"issue":"4","key":"10.3233\/JHD-240016_ref254","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed"},{"issue":"6","key":"10.3233\/JHD-240016_ref255","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localized in vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn Reson Med"},{"issue":"9","key":"10.3233\/JHD-240016_ref256","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/hbm.21339","article-title":"Functional and structural correlates of the aging brain: Relating visual cortex (V1) gamma band responses to age-related structural change","volume":"33","author":"Gaetz","year":"2012","journal-title":"Hum Brain Mapp"},{"issue":"Suppl 3","key":"10.3233\/JHD-240016_ref257","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-2011-0056","article-title":"Evaluation and tracking of Alzheimer\u2019s disease severity using resting-state magnetoencephalography","volume":"26","author":"Verdoorn","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JHD-240016_ref258","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nicl.2015.07.011","article-title":"A multicenter study of the early detection of synaptic dysfunction in mild cognitive impairment using magnetoencephalography-derived functional connectivity","volume":"9","author":"Maestu","year":"2015","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JHD-240016_ref259","doi-asserted-by":"crossref","first-page":"119344","DOI":"10.1016\/j.neuroimage.2022.119344","article-title":"A multi-site, multi-participant magnetoencephalography resting-state dataset to study dementia: The BioFIND dataset","volume":"258","author":"Vaghari","year":"2022","journal-title":"Neuroimage"},{"issue":"2","key":"10.3233\/JHD-240016_ref260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA Statement on p-Values: Context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"key":"10.3233\/JHD-240016_ref261","first-page":"103","article-title":"A critical review of the neuroimaging literature on synesthesia","volume":"9","author":"Hupe","year":"2015","journal-title":"Front Hum Neurosci"},{"key":"10.3233\/JHD-240016_ref262","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuroimage.2017.04.061","article-title":"Inference in the age of big data: Future perspectives on neuroscience","volume":"155","author":"Bzdok","year":"2017","journal-title":"Neuroimage"},{"issue":"1","key":"10.3233\/JHD-240016_ref263","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.media.2014.12.003","article-title":"Robust whole-brain segmentation: Application to traumatic brain injury","volume":"21","author":"Ledig","year":"2015","journal-title":"Med Image Anal"},{"issue":"5","key":"10.3233\/JHD-240016_ref264","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/practneurol-2013-000768","article-title":"Magnetoencephalography","volume":"14","author":"Proudfoot","year":"2014","journal-title":"Pract Neurol"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-240016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:25Z","timestamp":1777452985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-240016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":261,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-240016","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}